CGRP monoclonal antibodies in migraine: an efficacy and tolerability comparison with standard prophylactic drugs.

Fenne VandervorstLaura Van DeunAnnelies Van DyckeKoen PaemeleireUwe ReuterJean SchoenenJan Versijpt

Published in: The journal of headache and pain (2021)

Balancing the data presented in the current manuscript with additional data concerning long term safety on the one hand and cost issues on the other hand, can be of particular use to health policy makers to implement this new drug class in the prevention of migraine.

Keyphrases

public health
healthcare
electronic health record
mental health
big data
open label
randomized controlled trial
data analysis
emergency department
drug induced
adverse drug
artificial intelligence
human health
study protocol